Search

everythinglearnresearchcommunity

for

Search:↓

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Signaling pathways are crucial for hair growth in goats.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Early hair loss may indicate prostate issues.

Low iron levels are linked to more hair loss in non-menopausal women.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Cronkhite-Canada Syndrome often leads to death within 6-18 months.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Finasteride can cause sexual problems and depression in young men.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Women with PCOS have more emotional and body image issues than healthy women.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.